论文部分内容阅读
目的探讨米非司酮联合不同药物终止瘢痕子宫中期妊娠中的效果。方法选取我院2008年6月至2012年6月90例瘢痕子宫中期妊娠患者,将其分为研究组和对照组,研究组患者使用依沙吖啶和米非司酮联合疗法,对照组进行米索前列醇与米非司酮联合疗法,统计比较两组患者药物使用后的临床效果。结果通过治疗,研究组患者和对照组相比较,总有效率、胎盘胎膜的残留物、出血量、总产程以及宫缩时间等效果都要明显。结论通过本文研究发现,依沙吖啶与米非司酮联合终止瘢痕子宫中期妊娠,临床效果比较显著,具有较高的临床推广价值。
Objective To investigate the efficacy of mifepristone combined with different drugs in the termination of uterine scar pregnancy. Methods Totally 90 pregnant women with uterine scar of uterus from June 2008 to June 2012 were divided into study group and control group. The study group was treated with combination of ethacridine and mifepristone, and the control group Misoprostol and mifepristone combination therapy, statistical analysis of the clinical effect of two groups of patients after drug use. Results Through treatment, the study group of patients and control group compared to total effective rate, residual placental membranes, bleeding, total labor and the effect of contractions time should be obvious. Conclusion Through this study, we found that the combination of ethacridine and mifepristone termination of uterine scar pregnancy, the clinical effect is more significant, with high clinical value.